| Effect | None |
| Trial Design | Cohort |
| Trial Length | n/a |
| Number of Subjects | 30 |
| Gender | Both Genders |
| Age Range | 45-64 |
6 weeks of 400mg Sulbutiamine was unable to influence symptoms and signs of diabetic neuropathy although it did significantly benefit electrophysical readings; no influence was noted in blood glucose or HbA1c
